Adaptimmune治疗公共 ADAP 深 沪
等待开盘 09-02 09:30:00 美东时间
0.0589
-0.010
-14.51%
华盛通- 最 高0.0669
- 今 开0.0665
- 成交量 4146.31万股
- 最 低 0.0588
- 昨 收 0.0689
- 总市值 1560.85万
- 52周最高 1.165
- 市盈率 静 --
- 换手率 15.65%
- 52周最低 0.052
- 委 比 -1.48%
- 总股本 2.65亿
- 历史最高 21.57
- 量 比 0.78
- 振 幅 11.76%
- 历史最低 0.052
- 每 手 1
- 风险率 0.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Applied Digital Finalizes Additional 150MW Lease with CoreWeave in North Dakota
Applied Digital has finalized a new 150MW lease agreement with CoreWeave, bringing total capacity at its Polaris Forge 1 Campus to 400MW. This brings Applied Digital's anticipated revenue from these deals to $11B. The additional capacity will be housed in the third building of the campus, set to be operational in 2027. The campus is designed to scale up to 1GW, leveraging renewable energy and North Dakota's climate to reduce costs and emissions. ...
08-29 12:00
Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win
Argenx advances Vyvgart with strong trial data in seronegative gMG, driving growth projections and reinforcing its leadership in IgG-driven diseases.
08-27 01:35
Adaptimmune Therapeutics Stock (ADAP) Rockets 50% on CCO Severance Agreement
Adaptimmune Therapeutics stock rallied after the company reached a severance ag...
08-18 20:26
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Shares of Dayforce Inc (NYSE:DAY) rose sharply in pre-market trading. Bloomberg...
08-18 18:51
Adaptimmune Announces CCO Departure and Severance Agreement
Adaptimmune Therapeutics ( ($ADAP) ) has shared an update. On August 15, 2025, ...
08-16 05:06
Adaptimmune Therapeutics Q2 EPS $(0.02) Beats $(0.08) Estimate, Sales $13.677M Beat $9.914M Estimate
Adaptimmune Therapeutics (NASDAQ:ADAP) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.08) by 76.19 percent. This is a 150 percent decrease over earnings of $0.04 per share
08-13 19:37
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Y-mAbs Therapeutics (NASDAQ:YMAB) stock rose 103.2% to $8.52 during Tu...
08-06 01:06
Why Palantir Technologies Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
Shares of Palantir Technologies Inc. (NASDAQ:PLTR) rose sharply in pre-market t...
08-05 17:50
制药巨头扎堆做“减法”：20家药企7月宣布裁员
2025 年已经过半，裁员、削减成本，成为众多药企不得不面对的现实。据 Fierce Biotech 统计，仅在今年 7 月，就有 20 家药企宣布了裁员计划...
08-01 12:49
Vivakor Confirms Special Dividend of Adapti, Inc. Record Date Set for August 20, 2025
Vivakor, Inc. announced a record date of August 20, 2025, for a special dividend to shareholders. The dividend will be in the form of Adapti, Inc. common stock, with each Vivakor shareholder receiving approximately 0.0079 shares of Adapti based on the current stock price of $3.50, valuing the dividend at approximately $0.75 million. Vivakor currently holds 13.5% of Adapti's outstanding shares. Adapti recently completed its SEC registration and fi...
07-31 12:30
